Kamaldeep Kaur
Psychiatric/Mental Health · Phoenix, AZNPI 1043809478
Payments from drug & device makers
Across 98 payments — averaging $24.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$800
- Boehringer Ingelheim$461
- AbbVie$241
- AstraZeneca$238
- GSK$216
- Novo Nordisk$119
- plus $360 from 11 others
What the payments were for
- Consulting fees$80033%
- Food & beverage$1,63567%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 1 | $800 |
| Boehringer Ingelheim | 22 | $461 |
| AbbVie | 21 | $241 |
| AstraZeneca | 8 | $238 |
| GSK | 19 | $216 |
| Novo Nordisk | 6 | $119 |
| Exact Sciences | 4 | $79 |
| Sanofi-aventis U.S. LLC | 4 | $70 |
| Bayer | 3 | $55 |
| Lilly USA, LLC | 2 | $37 |
| Amarin Pharma, Inc. | 2 | $29 |
| Nevro Corp. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Vistapharm, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$800
- FARXIGA$117
How this compares
$2,435 in reported general payments places this provider in the 85th percentile of 1,230 psychiatric/mental health providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 23 | $31,186 |
| JanuviaSitagliptin Phosphate | 38 | $17,968 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 65 | $14,648 |
| FarxigaDapagliflozin Propanediol | 24 | $14,125 |
| JardianceEmpagliflozin | 12 | $13,135 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 19 | $8,929 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $8,599 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $1,877 |
| VascepaIcosapent Ethyl | 15 | $1,441 |
| Rosuvastatin Calcium | 52 | $1,099 |
| Omeprazole | 91 | $1,087 |
| Losartan Potassium | 114 | $858 |
| Atorvastatin Calcium | 95 | $846 |
| Metformin Hcl | 101 | $780 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $755 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $37 | $31,18623 claims |
| AstraZenecaFarxiga | $238 | $14,12524 claims |
| Boehringer IngelheimJardiance | $461 | $13,13512 claims |
| GSKTrelegy Ellipta | $216 | $8,59911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,230 psychiatric/mental health providers in Arizona.
Other psychiatric/mental health in Phoenix
- Elizabeth ElliottPhoenix$363K
- Russell HorningPhoenix$254K
- Claire ReecePhoenix$88K
- Luis FongPhoenix$59K
- Marilizabeth BirkPhoenix$34K
- Jaime LecomtePhoenix$15K
- Roger MayorgaPhoenix$10K
- Elena SassPhoenix$9K
- Martha SerranoPhoenix$8K
- Bonnie VogesPhoenix$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.